Quinazoline based EGFR inhibitors containing a zinc binding moiety

Details for Australian Patent Application No. 2012216752 (hide)

Owner Curis, Inc.

Inventors Qian, Changgeng; Cai, Xiong; Gould, Stephen; Zhai, Haixiao

Agent Pizzeys

Pub. Number AU-A-2012216752

Parent 2007296746

Filing date 11 September 2012

Wipo publication date 4 October 2012

International Classifications

C07D 239/88 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/04 Antineoplastic agents

C07D 239/93 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/94 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

27 September 2012 Complete Application Filed

4 October 2012 Application Open to Public Inspection

  Published as AU-A-2012216752

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216753-Portable ultrasonic flow measuring system, measuring devices and measuring tube

2012216751-Conduit, manufacture thereof and fusion process therefor